About the Master

Philip Scheltens is Director of the Alzheimer Center at Amsterdam UMC.

About the e-Clas

Alzheimer's disease is a progressive neurodegenerative disease. With the further aging of the world's population, the incidence of AD is rising year by year, resulting in a huge economic burden to the society. While the diagnosis of AD is still difficult at present, biomarkers are crucial for the accurate and early detection of AD, and are also a prerequisite for the effective treatment of the disease.